The MarketWatch News Division was not concerned in the creation of this content.
January 12, 2021 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / January 12, 2021 / Jakubowitz Law announces that securities fraud course motion lawsuits have commenced on behalf of shareholders of the pursuing publicly-traded companies who obtained shares in just the course periods mentioned under. Shareholders intrigued in symbolizing the course of wronged shareholders have until the guide plaintiff deadline to petition the courtroom. Your skill to share in any recovery doesn’t involve that you serve as a lead plaintiff. For far more details and to discuss with our business with no expense or obligation, comply with the inbound links beneath.
GoodRx Holdings, Inc (NASDAQ:GDRX)
Call JAKUBOWITZ ABOUT GDRX:
Class Interval: September 23, 2020 – November 16, 2020
Direct Plaintiff Deadline: February 16, 2021
The submitted grievance alleges that defendants made materially phony and/or deceptive statements and/or unsuccessful to disclose that: at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would quickly introduce its individual online and cellular prescription medication ordering and achievement support that would right contend with GoodRx. Defendants timed the IPO so that it was priced right before Amazon declared its on the internet pharmaceutical business to facilitate the IPO and create synthetic desire for the popular shares sold therein, as very well to maximize the sum of cash the Corporation and the selling stockholders could elevate in the IPO. Given defendants’ expertise of Amazon’s intention to enter the on the web pharmaceutical company, and their deceptive statements about GoodRx’s aggressive place built contemporaneously with that expertise, defendants’ materially fake and/or deceptive statements alleged herein were being manufactured willfully and prompted GoodRx typical stock to trade at artificially inflated charges in the course of the Course Period.
Triterras, Inc., f/k/a Netfin Acquisition Corp. (NASDAQ:TRIT)
Get hold of JAKUBOWITZ ABOUT TRIT:
Class Period: August 20, 2020 – December 16, 2020
Guide Plaintiff Deadline: February 19, 2021
The submitted grievance alleges that defendants created materially bogus and/or deceptive statements and/or unsuccessful to disclose that: (1) the extent to which Firm’s revenue progress relied on Triterras’ romance with Rhodium to refer end users to the Kratos platform (2) that Rhodium faced significant fiscal liabilities that jeopardized its ability to proceed as a going worry (3) that, as a end result, Rhodium was very likely to refer less consumers to the Company’s Kratos platform and (4) that, as a end result of the foregoing, Defendants’ positive statements about the Company’s enterprise, operations, and potential customers had been materially deceptive and/or lacked a affordable basis.
Tricida, Inc. (NASDAQ:TCDA)
Get hold of JAKUBOWITZ ABOUT TCDA:
Class Period: September 4, 2019 – Oct 28, 2020
Lead Plaintiff Deadline: March 8, 2021
The filed complaint alleges that defendants made materially wrong and/or deceptive statements and/or failed to disclose that: (i) Tricida’s NDA for veverimer was materially deficient (ii) appropriately, it was foreseeably probable that the Food and drug administration would not take the NDA for veverimer and (iii) as a final result, the Company’s community statements were being materially bogus and misleading at all pertinent periods.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the sufferer of securities fraud. Attorney promotion. Prior effects do not assurance comparable results.
1140 Avenue of the Americas
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
Source: Jakubowitz Law
View supply version on accesswire.com:
Copyright 2021 ACCESSWIRE
The MarketWatch Information Section was not associated in the development of this content material.